Mucocutaneous findings in febrile neutropenic children with acute leukemias

Journal of the Medical Association of Thailand

Volumn 88, Issue 6, 2005, Pages 817-823

  Wananukul, Siriwan ^a   Nuchprayoon, Issarang ^a   Siripanich, Hathaipan ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Acute lymphoblastic leukemic; Febrile neutropenia; Mucocutaneous findings; Mucositis

Indexed keywords

AMPHOTERICIN B; CIPROFLOXACIN;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANDIDIASIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MALE; MORBIDITY; MORTALITY; MUCOSA; PRACTICE GUIDELINE; PREVALENCE; PROSPECTIVE STUDY; SEPTICEMIA; SKIN INFECTION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MUCOUS MEMBRANE; NEUTROPENIA; PROSPECTIVE STUDIES; SKIN DISEASES;

EID: 22844442318     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pizzo PA. Management of fever in patients with cancer and treatment- induced neutropenia. NEJM 1993; 328: 1323-32.
2. Chanock SJ, Pizzo PA. Fever in the neutropenic host. Infectious Dis Clin North Am 1996; 10: 777-97.
3. Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 1996; 77: 791-8.
4. Susser WS, Whitaker-Worth, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40: 367-98.
5. Hughes WT, Amstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-51.
6. Link H, Bohme A, Comely OA, Hoffken K, Kellner O, Kern WV, et al. Antimicrobial therapy of unexplained fever in neutropenic patients. Guideline of the Infection diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft supportiv-massnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 2003; 82: S105-17.
7. Buchheidt D, Bohme A, Comely OA, Fatkenheuer G, Fuhr H, Heussel G, et al. Diagnosis and treatment of documented infections in neutropenic patients. Recommendations of the Infections Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003; 82: S127-32.
8. Donowitz GR, Maki DG, Crnich CJ, Pappas PG, Rolston KV. Infections in the neutropenic patient. New views of an old problem. Hematology 2001: 113-39.
9. Donnelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 2003; 3: 405-12.
10. Bergmann OJ. Oral infections and septicemia in immunocompromised patients with hematologic malignancies. J Clin Microbial 1988; 26: 2105-9.
11. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group. Am J Med 1989; 86: 668-72.
12. Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis 1992; 14: S49-53.
13. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogenic bone marrow transplant recipients. Clin Infect Dis 2001; 32: 1319-24.
14. Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H, et al. Fluconazole prophylaxis of fungal infection in patients with acute leukemia. Results of a randomized placebo-controlled, double, multicenter trial. Ann Intern Med 1993; 118: 495-503.
15. Glasmacher A, Prentice A, Gorschloter M, Engelkert S, Hahn C, Djulbegovic B, et al. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta- analysis of 3,597 patients. J Clin Oncol 2003; 21: 4615-26.
16. th ed. New York: Mc Graw-Hill 2003: 2059-70.
17. Whitley RJ, Roizman B. Herpes simplex virus infection. Lancet 2001; 357: 1513-8.
18. Bauerjee A, Brotherston T, Lamberty B, Campbell R. Cancer chemotherapy agent-induced perivenous extravasation injuries. Postgrad Med J 1987; 63: 5-9.
19. Punpanich W, Sawadichai K, Pratuangtham S, Hathirat P. Trends in bacterial infection in febrile neutropenic children: Ramathibodi Hospital. Thai J Pediatr 1999; 38: 9-16.
20. Chuvate A. Infection in febrile neutropenic children in acute leukemia in Chulalongkorn University Hospital [Thesis for the diploma of Thai board of Pediatrics of the Medical Council]. Chulalongkorn University 1998.
21. Anunnatsiri S, Chansung K, Chetchotisakol P, Sirijerachai C. Febrile Neutropenia: A retrospective study in Srinagarind Hospital. Srinagarind Med J 1997; 12: S26-7.
22. Glauser M. Empiric therapy of bacterial infecgions in patients with severe neutropenia. Diagn Microbiol Infect Dis 1998; 31: 467-72.
23. Oppenheim BA. The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 1998; 41: 7-11.
24. Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, Granena A, Gudiol F. Prospective stuey of 288 epiaodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbial Infect Dis 1996; 15: 291-6.